Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Christie M. Ballantyne

Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification
Oct 1, 2026, 13:01 | Science
Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification
Michael Honigberg, Associate Professor of Medicine at Harvard Medical School, Associate Editor at Journal of…
Mary Cushman: The Role of IL-6 in Cardiovascular Disease
Aug 26, 2026, 09:01 | Science
Mary Cushman: The Role of IL-6 in Cardiovascular Disease
Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont, shared a…
William Wallace: Does Fish Oil Increase Atrial Fibrillation Risk?
Aug 24, 2026, 04:02 | Science
William Wallace: Does Fish Oil Increase Atrial Fibrillation Risk?
William Wallace, Co-Founder and Chief Scientific Officer at Supplement Success Solutions, shared a post on LinkedIn:…
Hamdy Alkady: FDA Approves the First Oral PCSK9 Inhibitor
Aug 9, 2026, 07:54 | Science
Hamdy Alkady: FDA Approves the First Oral PCSK9 Inhibitor
Hamdy Alkady, Consultant Endocrinologist at King Fahad Armed Forces Hospital, shared a post on LinkedIn about…
Carlos Andrés Vergara Sánchez: Simultaneous Publications and Live Presentations at ACC26
Mar 30, 2026, 15:06 | Science
Carlos Andrés Vergara Sánchez: Simultaneous Publications and Live Presentations at ACC26
Carlos Andrés Vergara Sánchez, Chief Cardiovascular Disease Fellow at Mayo Clinic College of Medicine and…
Kausik Ray: Efficacy and Safety of Obicetrapib in Patients With HeFH on Maximally Tolerated Statins
Mar 13, 2026, 11:48 | Voices
Kausik Ray: Efficacy and Safety of Obicetrapib in Patients With HeFH on Maximally Tolerated Statins
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis…
Richard Keller: Efficacy and Safety of Enlicitide in High-Risk ASCVD Patients
Feb 17, 2026, 14:33 | Science
Richard Keller: Efficacy and Safety of Enlicitide in High-Risk ASCVD Patients
Richard Keller, Independent Contractor, Forensic Medical Reviewer and Physician Advisor Physician Advisor at CommonSpirit Health,…
Abdulla A. Damluji Summarizes CORAL Reef Trial
Feb 10, 2026, 14:32 | Science
Abdulla A. Damluji Summarizes CORAL Reef Trial
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, shared on…
Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
Nov 10, 2025, 10:16 | Science
Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on…
Lp(a) Testing in Primary Prevention: Cost-Effective Strategy to Reduce Cardiovascular Risk
Sep 14, 2025, 14:36 | Science
Lp(a) Testing in Primary Prevention: Cost-Effective Strategy to Reduce Cardiovascular Risk
Atherosclerosis has shared a post on LinkedIn: “Lp(a) Testing: A Cost-Saving Tool for Cardiovascular Prevention High…
All: 10 Posts: 1 - 100
NewsFeed